​

Clearside Biomedical (CLSD) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

CLSD Stock Rating

Clearside Biomedical stock's rating consensus is Buy, based on 13 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 13 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 13 0 13 Strong Sell Sell Hold Buy Strong Buy

CLSD Price Target Upside V Benchmarks

TypeNameUpside
StockClearside Biomedical-
SectorHealthcare Stocks 35.94%
IndustryBiotech Stocks 83.61%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$0.86$0.86$0.86
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 2534---7
Mar, 2534---7
Feb, 2534---7
Jan, 2534---7
Dec, 2434---7
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Aug 28, 2024H.C. WainwrightBuyBuyhold
Jun 24, 2024OppenheimerOutperforminitialise
May 13, 2024H.C. WainwrightBuyBuyhold
Mar 10, 2023NeedhamBuyBuyhold
Nov 09, 2022CLSABuyupgrade
Jun 16, 2021Roth CapitalBuyBuyhold

Financial Forecast

EPS Forecast

Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.39$0.01$-0.57$-0.53$-0.47----
Avg Forecast$-0.35$-0.17$-0.52$-0.54$-0.47$-0.45$-0.52$-0.24$0.05
High Forecast$0.02$0.01$-0.04$-0.52$-0.41$-0.33$-0.35$0.08$0.19
Low Forecast$-0.95$-0.46$-1.65$-0.58$-0.49$-0.53$-0.73$-0.49$-0.01
Surprise %11.43%-105.88%9.62%-1.85%-----

Revenue Forecast

$0 $60M $120M $180M $240M $300M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$7.89M$29.57M$1.33M$8.23M-----
Avg Forecast$9.49M$20.22M$1.10M$6.27M$1.68M$2.98M$13.24M$35.07M$81.94M
High Forecast$21.79M$46.42M$2.95M$8.17M$2.22M$9.21M$40.85M$108.24M$252.87M
Low Forecast$1.83M$3.89M$318.02K$2.47M$1.39M$342.41K$1.52M$4.02M$9.40M
Surprise %-16.80%46.29%20.83%31.12%-----

Net Income Forecast

$-150M $-110M $-70M $-30M $10M $50M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-18.03M$376.00K$-34.07M$-32.48M$-34.35M----
Avg Forecast$-21.88M$-10.63M$-31.89M$-32.48M$-27.67M$-26.70M$-33.38M$-12.67M$3.09M
High Forecast$1.09M$530.19K$-2.44M$-31.86M$-25.26M$-20.58M$-21.63M$4.94M$11.47M
Low Forecast$-58.75M$-28.54M$-101.73M$-36.07M$-30.08M$-32.82M$-45.12M$-30.29M$-466.21K
Surprise %-17.59%-103.54%6.83%-24.15%----

CLSD Forecast FAQ

Is Clearside Biomedical stock a buy?

Clearside Biomedical stock has a consensus rating of Buy, based on 13 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 13 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Clearside Biomedical is a favorable investment for most analysts.

What is Clearside Biomedical's price target?

Clearside Biomedical's price target, set by 13 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $0.86.

How does Clearside Biomedical stock forecast compare to its benchmarks?

Clearside Biomedical's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (35.94%) and underperforming the biotech stocks industry (83.61%).

What is the breakdown of analyst ratings for Clearside Biomedical over the past three months?

  • April 2025: 42.86% Strong Buy, 57.14% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 42.86% Strong Buy, 57.14% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 42.86% Strong Buy, 57.14% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Clearside Biomedical’s EPS forecast?

Clearside Biomedical's average annual EPS forecast for its fiscal year ending in December 2025 is $-0.45, marking a -4.26% decrease from the reported $-0.47 in 2024. Estimates for the following years are $-0.52 in 2026, $-0.24 in 2027, and $0.05 in 2028.

What is Clearside Biomedical’s revenue forecast?

Clearside Biomedical's average annual revenue forecast for its fiscal year ending in December 2025 is $2.98M, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $13.24M, followed by $35.07M for 2027, and $81.94M for 2028.

What is Clearside Biomedical’s net income forecast?

Clearside Biomedical's net income forecast for the fiscal year ending in December 2025 stands at $-26.701M, representing a -22.27% decrease from the reported $-34.352M in 2024. Projections indicate $-33.376M in 2026, $-12.67M in 2027, and $3.09M in 2028.